JNJ · News · 20260911N
Portfolio Reshaping (M&A / Divestiture)
JOHNSON & JOHNSON · 2026-09-11 · Importance 64 · Surprise 42 · In source text
Apollo Global Management is reportedly discussing the acquisition of Johnson & Johnson’s DePuy Synthes orthopedics unit. The potential transaction could be worth approximately $20 billion. DePuy Synthes generated $9.3 billion in 2025 and faces lawsuits, while J&J is evaluating alternatives including a potential public-company spin-off. The potential divestiture would support J&J’s strategy of focusing on higher-growth healthcare segments.
Key facts
- Apollo Global Management is reportedly in discussions to acquire Johnson & Johnson’s orthopedics unit, DePuy Synthes, in a deal potentially worth $20 billion. source
- Lone Peak Global Investors LLC decreased its holdings in Johnson and Johnson by 9.8% in the second quarter, owning 66,091 shares after selling 7,153 shares during the quarter. source
- Johnson & Johnson is trading near all-time highs, according to a Zacks article grouping Dividend Aristocrats including Johnson & Johnson. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | positive | contingent | +1.5% | Apollo Global Management is reportedly in discussions to acquire Johnson & Johnson’s orthopedics unit, DePuy Synthes, in a deal… |